Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight gain while taking Mounjaro is more common than most people expect, and it usually has a straightforward explanation. Tirzepatide works by reducing appetite and slowing digestion, yet several factors — dose adjustments, changes in routine, or how the body responds early in treatment — can push the scale upward temporarily. These are prescription-only medicines, so a GPhC-registered prescriber is the right person to review what's happening in your specific case. That said, there is a lot that clinical evidence and experience can tell us about why this happens and what it usually means.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you started Mounjaro a few weeks ago, you've been eating less, you feel different, and yet the scale shows you're heavier than when you began. It's a disheartening situation, and a question our prescribers hear most weeks.
The first thing worth knowing is that body weight is not a single measurement. It reflects fat, muscle, water, gut contents, and bone. Tirzepatide slows gastric emptying, which means food spends longer in your digestive tract. If you're also experiencing constipation (one of the more common early side effects noted in the NHS's patient guidance on tirzepatide) the gut can hold considerably more than usual. That alone can add one to three pounds to a morning weigh-in without any change in actual fat mass.
Fluid shifts are equally significant. When carbohydrate intake drops alongside reduced appetite, the body releases stored glycogen, and with it, the water bound to it. But stress hormones, medication timing, and hormonal cycles can all cause water retention that temporarily reverses this. For people who are also doing more strength-based exercise alongside treatment, muscle tissue holds more water than fat, so a body recomposing toward a healthier composition can show a higher weight for weeks before the trend becomes visible.
None of this means the treatment isn't working. Tracking waist circumference alongside weight gives a far more complete picture of what Mounjaro is actually doing to your body composition.
Tirzepatide is titrated gradually, starting at 2.5 mg for the first four weeks. That opening dose is a tolerability step, its job is to let your body adjust to the mechanism, not to deliver the appetite-suppression effect you'll experience at higher doses. Some people find their appetite barely changes at 2.5 mg or even 5 mg, and old eating habits can persist through those early weeks.
If you've gained weight during the titration phase, it's worth thinking honestly about what has changed in your eating since you started. Some people unconsciously relax dietary care once treatment begins, expecting the medicine to manage everything. Tirzepatide works best alongside a reduced-calorie approach, as the NICE appraisal of tirzepatide (TA1026) notes, the licence itself specifies use alongside dietary and activity changes.
It's also true that the weeks around a dose change can produce temporary fluctuations in both directions. If a dose increase caused stronger nausea and you responded by eating more bland, starchy foods than usual, that could account for a week or two of higher readings. This is temporary. Once the new dose settles and appetite suppression strengthens, most people find weight resumes falling. If you want to understand why you may have gained weight on Mounjaro, looking at the specific reasons behind each phase of treatment can help you interpret what's happening at each stage.
Temporary fluctuations are one thing. A sustained upward trend over three or more weeks, or a significant gain that doesn't correspond to any obvious dietary or lifestyle change, is a different situation and worth raising with your prescriber.
Thyroid function is one area clinicians consider: hypothyroidism can reduce the metabolic rate enough to blunt tirzepatide's effect, and it isn't always diagnosed before treatment begins. Certain other medications (some antidepressants, corticosteroids, and hormonal treatments) can independently drive weight gain and partially counteract what Mounjaro is doing. These interactions don't make treatment impossible, but they do change the clinical picture and may affect what dose or approach is appropriate.
Stress and sleep are less obvious but well-documented drivers. Chronic stress raises cortisol, which promotes fat storage and increases appetite for calorie-dense foods. Poor sleep disrupts ghrelin and leptin, the hormones that signal hunger and fullness, and can meaningfully undercut the appetite-suppressing effect of a GLP-1 and GIP dual agonist like tirzepatide. If your weight has been climbing and life has been harder than usual, that connection is worth acknowledging honestly.
If you're not sure whether what you're experiencing is normal variation or something that needs a closer look, the guidance on no weight loss on Mounjaro covers the clinical thresholds that matter. There's also a broader discussion of whether weight gain is possible on Mounjaro and what the evidence actually shows, and our dedicated page on putting weight on with Mounjaro explores the full range of reasons this can happen and how to respond. For context on how cost fits into choosing a reliable service, our Mounjaro cost guide sets out what an all-inclusive price should cover.
If you'd like a prescriber to review your situation properly, check your eligibility with nume, every consultation is read by a GPhC-registered Independent Prescriber the same day, not passed through automated screening.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.